Openbookopenbook
Equity
Adia Nutrition Inc(ADIA)
USD --+0.00%
Reward48Moderate
Risk66Medium-High
📊75%Data
Thin -56% profit margin
ADIA
+0.0 · +0.00%
USD · OTCQB
Adia Nutrition Inc | Financial Services
Speculative Momentum
Market Cap:17.84M
ℹ️
Reward Rating
48
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
66
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ADIA to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Adia Nutrition Inc?

offers medical treatments and nutritional supplements.

ADIA · Verdict

Moderate reward · elevated risk

ADIA's standout is volatility; profitability and cash flow weigh on the picture.

Based on 88% data coverage

ADIA · Verdict

What’s working & what to watch

Strengths 1

  • Volatility75/100

    Above average

Watchouts 3

  • Profitability9/100

    -56% net margin · -1461% ROE

  • Cash flow20/100

    -27% free-cash-flow margin

  • Balance sheet22/100

    Current ratio 1.11

Model-based scoring. For information only — not financial advice.

What is Adia Nutrition Inc?

offers medical treatments and nutritional supplements. It operates in three segments: Biolete, Adia Med, and Adia Labs. The company is listed on the OTCQB in USA, operating in the Financial Services sector, with a market capitalisation of 17.84M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Performance tied to macro conditions — sensitive to interest rate cycles.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (48)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorFinancial Services
Market Cap17.84M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.2777
52 Week Low0.023
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding94M
No. of Employees3
IndustryShell Companies
ExchangeOTCQB
Beta-9.768
CurrencyUSD
Websitewww.adianutrition.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.